kpv/bpc-157 BPC-157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank BPC-157 Europe - RUO Research

Common neurological manifestations include: Paraesthesia (pins and needles) in the hands and feet Numbness and altered sensation Difficulty with balance and coordination (ataxia) Memory problems and cognitive impairment Mood changes, including depression and irritability In severe cases, visual disturbances and confusion These neurological features arise from demyelination of peripheral nerves and the spinal cord, a condition known as subacute combined degeneration when it affects the posterior and lateral columns of the spinal cord

Tendon, Ligament, and Connective Tissue Due to limited blood supply, tendons and ligaments present significant challenges in repair research

Direct human dose-finding trials are limited

Stability considerations arise when combining peptides